Clinical trials
Phase 1 Sleep Apnea, Obstructive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2013 | 3 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Unknown status | 6 |
| Recruiting | 5 |
| Withdrawn | 3 |
| Terminated | 3 |
| Suspended | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brigham and Women's Hospital | 2 |
| Eisai Inc. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| University of Alberta | 2 |
| University of California, San Diego | 2 |
| Washington University School of Medicine | 2 |
| AGIR à Dom | 1 |
| Academic Centre for Dentistry in Amsterdam | 1 |
| Axsome Therapeutics, Inc. | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Apnea, Obstructive | 45 |
| Sleep Apnea Syndromes | 9 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Alzheimer Disease | 1 |
| Apnea | 1 |
| Asbestosis | 1 |
| Asthma | 1 |
| Bronchiectasis | 1 |
| Craniofacial Abnormalities | 1 |
| Cystic Fibrosis | 1 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.